Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
186.9 USD | -2.34% |
|
+2.60% | +8.67% |
06-25 | Oppenheimer Downgrades ResMed to Market Perform From Outperform | MT |
06-24 | Shares of ResMed, Inspire Medical Down After Eli Lilly Provides Sleep Apnea Study Update | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.67% | 27.46B | |
+2.06% | 207B | |
+5.69% | 181B | |
+29.31% | 155B | |
+1.37% | 64.42B | |
+18.36% | 54.38B | |
-1.92% | 47.43B | |
-8.53% | 37.17B | |
-1.37% | 34.81B | |
+14.23% | 23.45B |
- Stock Market
- Equities
- RMD Stock
- News ResMed, Inc.
- Transcript : ResMed Inc., Q2 2021 Earnings Call, Jan 28, 2021